Update: Global Good & QuantuMDx cervical cancer screening test

In February last year we announced a partnership with Intellectual Ventures’ Global Good fund, to develop a test to support cervical cancer screening in low- and middle-ncome countries (LMICs). We are jointly developing

Share
Tackling challenges to end tuberculosis

Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend

Share
QuantuMDx announces executive appointments

  QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the

Share
QuantuMDx: 10 years and 1 incredible journey

To celebrate our 10th birthday this year, we’ve produced an infographic to chart our incredible journey, from a makeshift laboratory in a Sussex garage, to performance testing of our Q-POC™ 

Share
Staff Spotlight: Jennifer Hannant

We’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions. This month we’ve interviewed Jennifer

Share
World TB Day: Engaging end users when developing diagnostics

To coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of care diagnostic tools for infectious

Share